In This Section

Updating the Opioid Crisis: Novel Approaches to Reducing Opioid Abuse and Overdose

Sunday April 05, 2020

8:00 am - 10:00 am

Room 16 AB
Sponsored by the Division for Behavioral Pharmacology (BEH)
Co-sponsored by the Division for Drug Discovery and Development (DDD)
Co-sponsored by the Division for Molecular Pharmacology (MP)

Chair :

Greg Collins
University of Texas Health Science Center at San Antonio

Sarah Withey
Mclean Hospital/Harvard Medical School

The United States is in the midst of an opioid epidemic, with current estimates placing the number of opioid-related deaths at more than 70,000 per year. This symposium will provide an update on the current state of the epidemic, with an eye towards challenges that we will face in the coming years. This symposium will also describe novel pharmacokinetic and pharmacodynamic approaches to combat opioid addiction and overdose, such as opioid-specific vaccines and pseudo-irreversible opioid receptor antagonists. Finally, this symposium will discuss innovative approaches to reduce opioid addiction through the development of non-opioid (or opioid-sparing) strategies to relieve pain.

The U.S. Opioid Crisis: Science = Solutions
Wilson Compton - National Institute on Drug Abuse (NIDA), NIH

Vaccines and Antibodies to Counteract Opioid use Disorders and Overdose
Marco Pravetoni - University of Minnesota

Methocinamox, A Novel and Long-lasting Approach to Treating Opioid Abuse and Overdose
Charles France - University of Texas Health Science Center at San Antonio

Reduction of Chronic Pain and Opioid Self-administration using Agmatine-based Therapeutics
Carolyn Fairbanks - University of Minnesota

Last Updated: November 8, 2019
Key Dates
March 6

Housing discounts end

March 13

Advance Registration Ends

April 3-4

GPCR Colloquium (separate ticket required)

April 4

ASPET Business Meeting and Awards Presentation

April 4-7

ASPET Annual Meeting at EB 2020

Thank you to our Annual Meeting partners:

University of Kentucky
Icahn School
University of Georgia
University of Minnesota
WSU Pharm-Pharm Sciences Unit
PR & P